On the morning of March 12, Liu Tongzhu, secretary of the party group of the Anhui Provincial Health and Health Commission, Zhao Zilin, former director of the Department of Planning and Finance of the Ministry of Health, and chairman of the sixth council of the China Medical Equipment Association, Zhao Minggang, former deputy director of the Medical Policy and Medical Reform Bureau of the Health and Family Planning Commission, and many Medical experts came to Fuqing Medical to discuss and exchange. Professor Qiu Bensheng, Chief Scientist of Fuqing Medical, Professor Long Chaoyang, Chief Strategy Officer, and Zhou Yufu, General Manager, received the expert group together with the relevant persons in charge of the company.

The expert group understands the development history of Fuqing Medical

The accompanying experts include: Zhu Liguo, President of Wangjing Hospital, China Academy of Chinese Medical Sciences; Wang Zhenchang, Vice President of Beijing Friendship Hospital Affiliated to Capital Medical University; Deputy Director of Surgery, Chief Physician Song Jinghai and others.

Secretary Liu Tongzhu and his party successively visited the CLIMBER148 superconducting magnetic resonance system independently developed by Fuqing Medical, the CLIMBER035 permanent magnetic magnetic resonance system, the cardiovascular interventional magnetic resonance system, the discrete intraoperative magnetic resonance system and the 7T ultra-high field scientific research magnetic resonance system. resonance system. After further understanding, Secretary Liu Tongzhu affirmed Fuqing Medical's research and development strength and the company's development speed.

Secretary Liu Tongzhu visited the magnetic resonance production workshop

After the visit, the two sides held a seminar on magnetic resonance imaging technology and intraoperative magnetic resonance technology. At the meeting, Dean Zhu Liguo pointed out from the perspective of spinal surgery that magnetic resonance will play a vital role in guiding the treatment of the cervical and lumbar spine, and fully expects Fuqing Medical to develop a special system for magnetic resonance-guided bone and joint intervention.

Dean Wang Zhenchang said that magnetic resonance-guided precision therapy is a brand-new track full of potential. Once successfully developed, it will have a huge impact on interventional therapy. He hopes that Fuqing Medical will persevere and become "specialized and refined, small and light." " direction forward.

Symposium and expert group active exchange

Director Liu Jinghua pointed out that cardiovascular MRI has technical advantages in cardiovascular structural imaging and coronary artery imaging. He encouraged Fuqing Medical to overcome difficulties, solve the core problem of imaging time, and help the diagnosis and treatment of cardiovascular diseases.

Director Song Jinghai said that magnetic resonance has obvious advantages in soft tissue imaging and is very suitable for guiding minimally invasive tumor surgery. The equipment is more likely to replace the existing interventional surgery equipment.

Director Zhao Minggang said that in the process of product development, we must combine actual clinical needs, actively cooperate with relevant departments including the State Food and Drug Administration, concentrate efforts, highlight advantages, and create unique product strengths.

Chairman Zhao Zilin expressed high recognition for Fuqing Medical's breakthrough from theory to application. He encouraged Fuqing Medical to speed up the transformation of scientific research results and move towards the goal of "developing one generation, applying one generation, and producing one generation". The equipment market has injected new vitality.

The two sides also conducted in-depth discussions on technical indicators and technical details of intraoperative magnetic resonance, cardiovascular interventional magnetic resonance, bone and joint interventional magnetic resonance, and magnetic resonance-guided radiotherapy.

The expert group visited and took a group photo